| Pharmaceutical Information |
| Drug Name |
Emedastine difumarate |
| Drug ID |
BADD_D00764 |
| Description |
Emedastine is an antihistamine used in eye drops to treat allergic conjunctivitis. |
| Indications and Usage |
For the temporary relief of the signs and symptoms of allergic conjunctivitis. |
| Marketing Status |
approved |
| ATC Code |
S01GX06 |
| DrugBank ID |
DB01084
|
| KEGG ID |
D02249
|
| MeSH ID |
C043345
|
| PubChem ID |
5282485
|
| TTD Drug ID |
D02XJI
|
| NDC Product Code |
12863-100 |
| UNII |
42MB94QOSM
|
| Synonyms |
emedastine | emedastine difumarate | 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate | KB 2413 | KG 2413 | KG-2413 | KB-2413 | Emadine |
|
| Chemical Information |
| Molecular Formula |
C25H34N4O9 |
| CAS Registry Number |
87233-62-3 |
| SMILES |
CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
